A Novel Approach to Infantile Spasms

Paused · Phase 3

Conditions studied: Infantile Spasm

In brief

This study proposes to assess the efficacy of Cosyntropin Injectable Suspension, 1 mg/mL compared to vigabatrin. Additionally, this study proposes to determine efficacy of combination therapy of Cosyntropin Injectable Suspension, 1 mg/mL and vigabatrin to monotherapy Cosyntropin Injectable Suspension, 1mg/mL in children with new onset infantile spasms (IS).

Key facts

Study ID
NCT03347526
Run by
University of Colorado, Denver
People needed
394
Starts
2018-04-19
Expected to finish
2021-08-01
Last updated by the study team
2021-05-27

Who can join

Age: 0 and older, up to 2. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.